influvac tetra suspension for injection in pre-filled syringe
abbott biologicals, netherlands - a/brisbane/02/2018 (h1n1),a/kansas/14/2017 (h3n2),b/colorado/06/2017,b/phuket/3073/2013 - suspension for injection in pre-filled syringe - 15,15,15,15 µg,
influvac sub-unit suspension for injection
mylan products limited - influenza vaccine (split virion, inactivated) - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) 15 µg - vaccines
influvac sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated)
mylan ire healthcare limited - a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/2570/2019, ivr-215) ; a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr-224); b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection in pre-filled syringe - 0.5 microgram(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen
influvac desu vaccine suspension for injection 0.5ml pre-filled syringes
abbott healthcare products ltd - influenza virus surface antigens - suspension for injection
influvac sub-unit tetra vaccine suspension for injection 0.5ml pre-filled syringes
viatris uk healthcare ltd - influenza virus surface antigens - suspension for injection
influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe with 16 mm needle, 2024
viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.
influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe with 25 mm needle 2024
viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.
influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe without needle 2024
viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.
influvac s inj. susp. s.c./i.m. pre-filled syr.
viatris bv-srl - influenza virus, inactivated, trivalent - suspension for injection in pre-filled syringe - influenza virus, inactivated, trivalent - influenza, inactivated, split virus or surface antigen
influvac tetra inj. susp. s.c./i.m. pre-filled syr.
viatris healthcare sa-nv - influenzavirus a-h3n2 surface antigen 15 µg/dose; influenzavirus b surface antigen 15 µg/dose; influenzavirus b surface antigen 15 µg/dose; influenzavirus a-h1n1 surface antigen 15 µg/dose - suspension for injection in pre-filled syringe - influenza virus, inactivated, tetravalent, haemagglutinine and neuraminidase units - influenza, inactivated, split virus or surface antigen